Product Program year 2024 Source: CMS Open Payments

Nt2000ix

Device Neuromodulation

PDI 05415067022417

Open in the dashboard

General payments

$38,335

221 payments

Research payments

$0

0 payments

Through program year 2024, $38,335 in general payments and $0 in research payments were reported against Nt2000ix (Neuromodulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $156 8
2023 General $527 23
2022 General $37,651 190

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $38,335 221 payments
Top recipients General payments · program year 2024
  1. Ali Daha Pain Medicine · Lakeway, TX $40 26% · 1 payment
  2. Derrick Randall Pain Medicine · Charleston, SC $36 23% · 2 payments
  3. Austin Albright Pain Medicine · Salt Lake City, UT $26 16% · 1 payment
  4. James Dvorak Physical Medicine & Rehabilitation · Saint Louis Park, MN $26 16% · 1 payment
  5. Sridhar Pinnamaneni Pain Medicine · Leesburg, FL $13 8% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Pain Medicine Anesthesiology $55 35% · 3 practitioners
  2. Pain Medicine $49 32% · 2 practitioners
  3. Pain Medicine Physical Medicine & Rehabilitation $26 16% · 1 practitioner
  4. Physical Medicine & Rehabilitation $26 16% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Texas $40 26% · 1 recipient
  2. South Carolina $36 23% · 1 recipient
  3. Utah $26 16% · 1 recipient
  4. Minnesota $26 16% · 1 recipient
  5. Florida $13 8% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

221 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record